Disturbances in Heart Rhythm
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias VI: Management of Dysrhythmias
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 4, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Sarrah Kastalli1, Sihem El Aïdli, Sami Mourali
1Service de recueil et analyse des effets indésirables, Centre National de Pharmacovigilance, 9 Av Dr Zouheir Essafi 1006 Tunis, Tunisia.
Cardiac adverse effects are rare with interferon (INF) beta. This case study details a patient who developed left bundle branch block after INF beta-1a treatment for multiple sclerosis, which resolved after discontinuation.
Area of Science:
Background: